Delivery Order SPE2DB20D3103-SPE2DB25FN2E4

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 50 MG CAPSULE 100S. The contract has a firm fixed-price structure and a ceiling value of $1,370.12, with a completion date of November 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,801.92, is for the delivery of VYVANSE 60 MG CAPSULE 100S, a medication. The contract has a firm fixed price pricing type and a completion date of January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563696090 - VYVANSE 30 MG CAPSULE 100S. The contract has a ceiling value of $4,998.54 and runs through February 20, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,265,916 units of the medication VYVANSE 10 MG CAPSULE 100S, with a ceiling value of $1,320.90. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) with a period of performance through July 29, 2024. Amerisourcebergen is not operating under a set-aside designation for this award. This delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 40 MG CAPSULE 100S. The contract has a ceiling value of $3,433.26 and runs through February 24, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $13,780.61 firm fixed-price contract is for the delivery of 4,567,612,803 units of the prescription medication VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYVANSE 20 MG CAPSULE 100S. The award has a ceiling value of $1,673.36 and a completion date of September 10, 2024. The contract is a Firm Fixed Price type. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000, respectively,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Vyvanse 20 mg capsules. The contract has a ceiling value of $4,065.21 and runs through January 23, 2025. It is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 50 mg capsules. The contract has a ceiling value of $1,258.30 and a period of performance through May 9, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a ceiling value of $3,146.34 and a period of performance through December 3, 2024. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN2E4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4567721242 VYVANSE 60 MG CAPSULE 100S. The contract has a total ceiling value of $8,535.33 and runs through March 28, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order appears to be part of this larger IDC contract with the DLA.

Generated 6/26/25, 10:06 AM